AI assistant
Vitrolife Board/Management Information 2019
2989_rns_2019-10-07_c5ba3a85-3e3c-42f9-a9a5-dfa0927ac8bb.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Press release October 7, 2019 Gothenburg
Election committee for Vitrolife AB (publ)
The following people have been appointed as members of Vitrolife's election committee for the Annual General Meeting in 2020:
Niels Jacobsen, representing William Demant Invest A/S Patrik Tigerschiöld, representing Bure Equity AB Wendy Wang, representing Morgan Stanley Investment Management Inc. Jón Sigurdsson, Chairman of the Board
The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vitrolife on May 2, 2019.
The Annual General Meeting of Vitrolife AB (publ) will be held on April 28, 2020 in Gothenburg.
Shareholders who wish to have an item considered at the Annual General Meeting can submit a request to the Board to this effect. Such a request for an item to be considered is to be sent to Vitrolife AB (publ), Att: Chairman of the Board, Box 9080, 400 92 Gothenburg, and must have been received by the Board no later than seven weeks before the Annual General Meeting, or otherwise in such good time that the matter, where necessary, can be included in the notice to attend the Annual General Meeting.
Gothenburg, October 7, 2019
VITROLIFE AB (publ)
Contact:
Jón Sigurdsson, Chairman of the Board, email: [email protected] Mikael Engblom, CFO, phone +46 31 7218014
___________________________________________________________________________________________________________________________________
. _____________________________________________________________________________________________________
Vitrolife AB (publ), Box 9080, SE-400 92 Gothenburg. Corporate ID number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 99. E-mail: [email protected]. Website: www.vitrolife.com
This information is information that Vitrolife AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 9.00 am CET on October 7, 2019.